Unknown

Dataset Information

0

Perfused Three-dimensional Organotypic Culture of Human Cancer Cells for Therapeutic Evaluation.


ABSTRACT: Pharmaceutical research requires pre-clinical testing of new therapeutics using both in-vitro and in-vivo models. However, the species specificity of non-human in-vivo models and the inadequate recapitulation of physiological conditions in-vitro are intrinsic weaknesses. Here we show that perfusion is a vital factor for engineered human tissues to recapitulate key aspects of the tumour microenvironment. Organotypic culture and human tumour explants were allowed to grow long-term (14-35 days) and phenotypic features of perfused microtumours compared with those in the static culture. Differentiation status and therapeutic responses were significantly different under perfusion, indicating a distinct biological response of cultures grown under static conditions. Furthermore, heterogeneous co-culture of tumour and endothelial cells demonstrated selective cell-killing under therapeutic perfusion versus episodic delivery. We present a perfused 3D microtumour culture platform that sustains a more physiological tissue state and increased viability for long-term analyses. This system has the potential to tackle the disadvantages inherit of conventional pharmaceutical models and is suitable for precision medicine screening of tumour explants, particularly in hard-to-treat cancer types such as brain cancer which suffer from a lack of clinical samples.

SUBMITTER: Wan X 

PROVIDER: S-EPMC5573358 | biostudies-literature | 2017 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Perfused Three-dimensional Organotypic Culture of Human Cancer Cells for Therapeutic Evaluation.

Wan Xiao X   Ball Steven S   Willenbrock Frances F   Yeh Shaoyang S   Vlahov Nikola N   Koennig Delia D   Green Marcus M   Brown Graham G   Jeyaretna Sanjeeva S   Li Zhaohui Z   Cui Zhanfeng Z   Ye Hua H   O'Neill Eric E  

Scientific reports 20170825 1


Pharmaceutical research requires pre-clinical testing of new therapeutics using both in-vitro and in-vivo models. However, the species specificity of non-human in-vivo models and the inadequate recapitulation of physiological conditions in-vitro are intrinsic weaknesses. Here we show that perfusion is a vital factor for engineered human tissues to recapitulate key aspects of the tumour microenvironment. Organotypic culture and human tumour explants were allowed to grow long-term (14-35 days) and  ...[more]

Similar Datasets

| S-EPMC4754778 | biostudies-literature
| S-EPMC3626791 | biostudies-literature
| S-EPMC5239492 | biostudies-other
| S-EPMC4427252 | biostudies-literature
| S-EPMC4468434 | biostudies-literature
| S-EPMC9139376 | biostudies-literature
| S-EPMC4990973 | biostudies-literature
| S-EPMC3141259 | biostudies-literature
| S-EPMC5717437 | biostudies-literature
| S-EPMC3586217 | biostudies-literature